Aspect Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25
Closed -$3.11K 731
2025
Q2
$3.11K Hold
25
﹤0.01% 425
2025
Q1
$3.18K Hold
25
﹤0.01% 396
2024
Q4
$3.6K Hold
25
﹤0.01% 407
2024
Q3
$3.72K Hold
25
﹤0.01% 388
2024
Q2
$3.15K Sell
25
-325
-93% -$50.9K ﹤0.01% 406
2024
Q1
$64.4K Sell
350
-50
-13% -$9.52K 0.05% 109
2023
Q4
$71.9K Buy
+400
New +$62.3K 0.05% 100

Other funds holding RGEN

Aspect Partners's RGEN Position: Q3 2025 in Review

Aspect Partners sold out of Repligen (RGEN) in Q3 2025, closing a stake of 25 shares — an estimated $3.11K sold.

Aspect Partners first reported a position in RGEN in Q4 2023 and held it in 7 quarters. The position peaked at $71.9K in Q4 2023. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Aspect Partners reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Aspect Partners sold 25 Repligen shares in Q3 2025, an estimated $3.11K.
  • Aspect Partners first reported a position in Repligen in Q4 2023 and held it in 7 quarters.
  • Aspect Partners's Repligen position peaked at $71.9K in Q4 2023.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Aspect Partners's 13F filing for Q3 2025, filed 6 Nov 2025.